Insider Transactions Reported by 9 Insiders of Ambrx Biopharma, Inc.

Location
La Jolla, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Ambrx Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cormorant Asset Management, LP 10%+ Owner $110,288,420 23 Oct 2023
Andrew Aromando Chief Operating Officer $1,072,963 07 Mar 2024
Janet Loesberg Director $0 07 Mar 2024
Kate Hermans Director $0 07 Mar 2024
Daniel J. O'Connor President and CEO, Director $0 07 Mar 2024
Sonja Nelson Chief Financial Officer $0 07 Mar 2024
Stephen C. Glover Director $0 07 Mar 2024
Margaret Dalesandro Director $0 07 Mar 2024
Paul Maier V Director 07 Mar 2024

Recent Insider Transactions by Companies or Individuals for Ambrx Biopharma, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.